207 related articles for article (PubMed ID: 20949131)
1. Profiling of substrate specificity of SARS-CoV 3CL.
Chuck CP; Chong LT; Chen C; Chow HF; Wan DC; Wong KB
PLoS One; 2010 Oct; 5(10):e13197. PubMed ID: 20949131
[TBL] [Abstract][Full Text] [Related]
2. Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses.
Chuck CP; Chow HF; Wan DC; Wong KB
PLoS One; 2011; 6(11):e27228. PubMed ID: 22073294
[TBL] [Abstract][Full Text] [Related]
3. Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL
Cesar Ramos de Jesus H; Solis N; Machado Y; Pablos I; Bell PA; Kappelhoff R; Grin PM; Sorgi CA; Butler GS; Overall CM
J Virol; 2024 Jun; 98(6):e0004924. PubMed ID: 38742901
[TBL] [Abstract][Full Text] [Related]
4. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM
Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962
[TBL] [Abstract][Full Text] [Related]
5. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.
Muramatsu T; Takemoto C; Kim YT; Wang H; Nishii W; Terada T; Shirouzu M; Yokoyama S
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):12997-13002. PubMed ID: 27799534
[TBL] [Abstract][Full Text] [Related]
7. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
[TBL] [Abstract][Full Text] [Related]
8. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an alphamesonivirus 3C-like protease defines a special group of nidovirus main proteases.
Blanck S; Stinn A; Tsiklauri L; Zirkel F; Junglen S; Ziebuhr J
J Virol; 2014 Dec; 88(23):13747-58. PubMed ID: 25231310
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the maturation process of SARS-CoV 3CL protease.
Hsu MF; Kuo CJ; Chang KT; Chang HC; Chou CC; Ko TP; Shr HL; Chang GG; Wang AH; Liang PH
J Biol Chem; 2005 Sep; 280(35):31257-66. PubMed ID: 15788388
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
[TBL] [Abstract][Full Text] [Related]
12. Study on substrate specificity at subsites for severe acute respiratory syndrome coronavirus 3CL protease.
Shan YF; Xu GJ
Acta Biochim Biophys Sin (Shanghai); 2005 Dec; 37(12):807-13. PubMed ID: 16331324
[TBL] [Abstract][Full Text] [Related]
13. An engineered viral protease exhibiting substrate specificity for a polyglutamine stretch prevents polyglutamine-induced neuronal cell death.
Sellamuthu S; Shin BH; Han HE; Park SM; Oh HJ; Rho SH; Lee YJ; Park WJ
PLoS One; 2011; 6(7):e22554. PubMed ID: 21799895
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
Xu S; Zhou J; Chen Y; Tong X; Wang Z; Guo J; Chen J; Fang L; Wang D; Xiao S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32727876
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
17. Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays.
Chen L; Chen S; Gui C; Shen J; Shen X; Jiang H
J Biomol Screen; 2006 Dec; 11(8):915-21. PubMed ID: 17092912
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
Wang W; Liang TC
Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
